(19)

(11)

EP 4 824 103 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24904953.7 (22) Date of filing: 13.12.2024

(51) International Patent Classification (IPC):  C07K 16/28(2006.01) A61P 35/00(2006.01) G01N 33/533(2006.01) (52) Cooperative Patent Classification (CPC): A61K 2039/505; G01N 33/6872; G01N 2333/70596; A61P 35/00; C07K 2317/92; C07K 16/2851; C07K 2317/76; G01N 33/5759 (86) International application number: PCT/US2024/060002 (87) International publication number: WO 2025/128975 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 14.12.2023 US 202363610044 P (71) Applicant: Immunitas Therapeutics, Inc. Waltham, Massachusetts 02451 (US)	(72) Inventors: IRVINE, Frano-Joseph Waltham, Massachusetts 02451 (US) TISDALE, Alison Waltham, Massachusetts 02451 (US) (74) Representative: Mathys & Squire  32 London Bridge Street The Shard London SE1 9SG London SE1 9SG (GB)